Release Date: 30/12/14 12:29 Summary: Share Consolidation and Name Change Price Sensitive: No Download Document 216.25KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%